AU2003301857A1 - New process for the preparation of racemic ((2s(2r*(r(r*)))) and ((2r(2s*(s(s*))))-(plus or minus)- alpha,alpha' -(imino-bis(methylene))bis(6-fluoro-chroman-2-methanol) and its pure (2s(2r*(r(r*)and - Google Patents

New process for the preparation of racemic ((2s(2r*(r(r*)))) and ((2r(2s*(s(s*))))-(plus or minus)- alpha,alpha' -(imino-bis(methylene))bis(6-fluoro-chroman-2-methanol) and its pure (2s(2r*(r(r*)and

Info

Publication number
AU2003301857A1
AU2003301857A1 AU2003301857A AU2003301857A AU2003301857A1 AU 2003301857 A1 AU2003301857 A1 AU 2003301857A1 AU 2003301857 A AU2003301857 A AU 2003301857A AU 2003301857 A AU2003301857 A AU 2003301857A AU 2003301857 A1 AU2003301857 A1 AU 2003301857A1
Authority
AU
Australia
Prior art keywords
alpha
bis
chroman
imino
racemic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003301857A
Inventor
Gabor Berecz
Jozsef Reiter
Gyula Simig
Peter Trinka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Egis Pharmaceuticals PLC
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Egis Pharmaceuticals PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar, Egis Pharmaceuticals PLC filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of AU2003301857A1 publication Critical patent/AU2003301857A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/26—Radicals substituted by doubly bound oxygen or sulfur atoms or by two such atoms singly bound to the same carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/535—Organo-phosphoranes
    • C07F9/5352—Phosphoranes containing the structure P=C-
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C07F9/5456—Arylalkanephosphonium compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AU2003301857A 2002-11-06 2003-11-06 New process for the preparation of racemic ((2s(2r*(r(r*)))) and ((2r(2s*(s(s*))))-(plus or minus)- alpha,alpha' -(imino-bis(methylene))bis(6-fluoro-chroman-2-methanol) and its pure (2s(2r*(r(r*)and Abandoned AU2003301857A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HU0203810A HU227236B1 (en) 2002-11-06 2002-11-06 New process for the production of racemic and the pure [2s[2r*[r[r*]]]]-and [2r[2s*[s[s*]]]]-enantiomers of nebivolol
HUP0203810 2002-11-06
PCT/HU2003/000093 WO2004041805A1 (en) 2002-11-06 2003-11-06 NEW PROCESS FOR THE PREPARATION OF RACEMIC ([2S[2R*[R[R*]]]] and ([2R[2S*[S[S*]]]]-(±)- α,α' -[imino-bis(methylene)]bis[6-fluoro­chroman-2-methanol] AND ITS PURE [2S[2R*[R[R*]&

Publications (1)

Publication Number Publication Date
AU2003301857A1 true AU2003301857A1 (en) 2004-06-07

Family

ID=89980906

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003301857A Abandoned AU2003301857A1 (en) 2002-11-06 2003-11-06 New process for the preparation of racemic ((2s(2r*(r(r*)))) and ((2r(2s*(s(s*))))-(plus or minus)- alpha,alpha' -(imino-bis(methylene))bis(6-fluoro-chroman-2-methanol) and its pure (2s(2r*(r(r*)and

Country Status (3)

Country Link
AU (1) AU2003301857A1 (en)
HU (1) HU227236B1 (en)
WO (1) WO2004041805A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1737847B1 (en) 2004-07-30 2008-06-04 Torrent Pharmaceuticals Ltd Nebivolol and its pharmaceutically acceptable salts, process for preparation and pharmaceutical compositions of nebivolol
JP4769464B2 (en) * 2005-01-12 2011-09-07 広栄化学工業株式会社 Method for producing alcohol compound
US7560575B2 (en) * 2005-12-28 2009-07-14 Acino Pharma Ag Process for preparation of racemic Nebivolol
EP1803716B1 (en) * 2005-12-28 2012-07-25 Acino Pharma AG A process for preparation of racemic nebivolol
ITMI20061889A1 (en) * 2006-10-03 2008-04-04 Zambon Spa NEBIVOLOL PREPARATION PROCESS
CN103087028B (en) * 2006-11-27 2014-12-24 Zach系统股份公司 Process for preparing nebivolol
JP5281012B2 (en) * 2006-11-27 2013-09-04 ザック システム エス．ピー．エー． Preparation method of nebivolol
IT1392067B1 (en) * 2008-10-31 2012-02-09 Zach System Spa NEBIVOLOL PREPARATION PROCESS
WO2010089764A2 (en) * 2009-01-05 2010-08-12 Msn Laboratories Limited Improved process for the preparation of nebivolol hydrochloride
DE102010005953A1 (en) 2010-01-27 2011-07-28 Corden PharmaChem GmbH, 68305 Process for the preparation of nebivolol
IT1397962B1 (en) * 2010-02-11 2013-02-04 Menarini Int Operations Lu Sa PROCESS FOR NEBIVOLOL PREPARATION.
CN102344431B (en) * 2010-08-05 2014-03-26 成都康弘药业集团股份有限公司 Method for preparing nebivolol hydrochloride
ITRM20110418A1 (en) * 2011-08-02 2013-02-03 Menarini Int Operations Lu Sa PROCESS FOR THE PREPARATION OF EPOXY WHICH INTERMEDIATES FOR THE SYNTHESIS OF NEBIVOLOL.
EP2907810A1 (en) 2014-02-14 2015-08-19 Corden Pharma International GmbH A new method for producing nebivolol hydrochloride of high purity
EP2907809B1 (en) 2014-02-14 2018-08-22 Corden Pharma International GmbH Base-free process for the preparation of ketone intermediates usable for manufacture of nebivolol
DE102014107132A1 (en) 2014-05-20 2015-11-26 Corden Pharma International Gmbh Process for the preparation of epoxides which can be used in the preparation of nebivolol and its derivatives
CN105085499B (en) * 2015-08-07 2018-09-25 上海现代制药海门有限公司 The Crystallization Separation method of nebivolol hydrochloric acid intermediate mixture
CN108997420B (en) * 2018-08-31 2020-11-13 湖北大学 Synthesis method of triphenyl-n- (colchicine amido) butyl phosphonium chloride compound and application of triphenyl-n- (colchicine amido) butyl phosphonium chloride compound in antitumor drugs

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4654362A (en) * 1983-12-05 1987-03-31 Janssen Pharmaceutica, N.V. Derivatives of 2,2'-iminobisethanol

Also Published As

Publication number Publication date
HUP0203810A2 (en) 2004-09-28
HU0203810D0 (en) 2003-01-28
WO2004041805A1 (en) 2004-05-21
HUP0203810A3 (en) 2004-10-28
HU227236B1 (en) 2010-12-28

Similar Documents

Publication Publication Date Title
AU2003301857A1 (en) New process for the preparation of racemic ((2s(2r*(r(r*)))) and ((2r(2s*(s(s*))))-(plus or minus)- alpha,alpha' -(imino-bis(methylene))bis(6-fluoro-chroman-2-methanol) and its pure (2s(2r*(r(r*)and
AU2002363236A1 (en) Compounds, pharmaceutical compositions and methods of use therefor
IL190218A0 (en) Novel compounds, pharmaceutical compositions containing same, and methods of use for same
AU2003233010A1 (en) Process for the preparation of 3,3,4,4-tetrafluoropyrrolidine and derivatives thereof
HK1086485A1 (en) Novel compounds, pharmaceutical compositions containing same, and methods of use for same
HUP0103913A3 (en) Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same
AU2003293405A1 (en) Pharmaceutical composition of 1-(3,4-dimethoxyphenyl)-4-methyl-5-ethyl-7-methoxy-8-hydroxy-5h-2,3-benzodiazepine and uses thereof
IL165012A0 (en) (S)-4-Amino-5-chloro-2-methoxy-N-Ä1-(-tetrahydrofurylcarbonyl)-4-piperidinylmethylÜ-4-piperidinylÜbenzamide, process for the preparation thereof, pharmaceutical composition containing the same, and intermediate therefor
WO2004000859A3 (en) Etoposide analogs and methods of use thereof
HUP0101839A3 (en) Heterocyclically substituted amides with cysteine protease-inhibiting effect, use of them for producing pharmaceutical compositions and pharmaceutical compositions containing them
IL176523A0 (en) Ascorbic acid compounds, methods of synthesis and application use thereof
IL159067A0 (en) METHODS FOR PREPARATION AND USE OF 1alpha,24 (S) -DIHYDROXYVITAMIN D2
AU2003275056A1 (en) Novel lapacho compounds and methods of use thereof
AU2003236118A1 (en) An antispastic, analgetic pharmaceutical composition and the preparation method thereof as well as the quality control technique therefor
SI1477480T1 (en) Method for racemisation of (S)-(+)- and (R)-(-)-10,11-dihydro-10-hydroxy-5H-dibenz-b,f-azepine-5-carboxamide and optically enriched mixtures thereof
WO2003020963A3 (en) Proteins in type 2 diabetes
AU2002246983A1 (en) 1,2-disubstituted cyclic inhibitors of matrix metallorproteases and tnf-alpha
EP1617810A4 (en) Methods for preparation and use of 1alpha,24(s)-dihydroxyvitamin d2
AU2002303529A1 (en) Antidepressant azaheterocyclylmethyl derivatives of 1,4,5-trioxa-phenanthrene
NO20005259L (en) Process for the preparation of enantiomerically pure N-methyl-N - [(1S) -1-phenyl-2 - ((3S) -3-hydroxypyrrolidin-1-yl) ethyl] -2,2-diphenylacetamide
AU2002335980A1 (en) Fibrinogen biopolymer marker and its use for the screening of type ii diabetes
AU1153201A (en) Uses of 1,25-dihydroxy-5,6-trans vitamin D compounds and derivatives thereof
AU2003223098A1 (en) Novel process for the preparation of substantially pure 5-(3,5-dimethylphenoxy)methyl-2-oxazolidinone
AU2003288109A1 (en) Cosmetic composition, containing coumarin derivatives and lipophilic amino acid derivatives
AU2002361993A1 (en) Method for the permanent deformation of keratin fibres, and agent

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase